Deliang Guo

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Advanced Non Small Cell Lung Cancer

Drug Administration

Top Venues

Nature communications

Cancer research

Molecular & cellular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Chandra Bhushan Prasad, Adrian Oo, Yujie Liu, Zhaojun Qiu, Yaogang Zhong, Na Li, Deepika Singh, Xiwen Xin, Young-Jae Cho, Zaibo Li, Xiaoli Zhang, Chunhong Yan, Qingfei Zheng, Hongbing Wang, Deliang Guo, Baek Kim, Junran Zhang
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity. Nature communications 15 (1) (2024)
Chandra Bhushan Prasad, Adrian Oo, Yujie Liu, Zhaojun Qiu, Yaogang Zhong, Na Li, Deepika Singh, Xiwen Xin, Young-Jae Cho, Zaibo Li, Xiaoli Zhang, Chunhong Yan, Qingfei Zheng, Hongbing Wang, Deliang Guo, Baek Kim, Junran Zhang
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity. Nature communications 15 (1) (2024)
Peng Sun, Juanjuan Liu, Deliang Guo
Tumor cells utilize acetate for tumor growth and immune evasion. MedComm 5 (9) (2024)
Chandra Bhushan Prasad, Adrian Oo, Yujie Liu, Zhaojun Qiu, Yaogang Zhong, Na Li, Deepika Singh, Xiwen Xin, Young-Jae Cho, Zaibo Li, Xiaoli Zhang, Chunhong Yan, Qingfei Zheng, Hongbing Wang, Deliang Guo, Baek Kim, Junran Zhang
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity. Nature communications 15 (1) (2024)
Peng Sun, Juanjuan Liu, Deliang Guo
Tumor cells utilize acetate for tumor growth and immune evasion. MedComm 5 (9) (2024)
Chandra Bhushan Prasad, Adrian Oo, Yujie Liu, Zhaojun Qiu, Yaogang Zhong, Na Li, Deepika Singh, Xiwen Xin, Young-Jae Cho, Zaibo Li, Xiaoli Zhang, Chunhong Yan, Qingfei Zheng, Hongbing Wang, Deliang Guo, Baek Kim, Junran Zhang
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity. Nature communications 15 (1) (2024)
Chandra Bhushan Prasad, Adrian Oo, Yujie Liu, Zhaojun Qiu, Yaogang Zhong, Na Li, Deepika Singh, Xiwen Xin, Young-Jae Cho, Zaibo Li, Xiaoli Zhang, Chunhong Yan, Qingfei Zheng, Hongbing Wang, Deliang Guo, Baek Kim, Junran Zhang
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity. Nature communications 15 (1) (2024)
Chandra Bhushan Prasad, Adrian Oo, Yujie Liu, Zhaojun Qiu, Yaogang Zhong, Na Li, Deepika Singh, Xiwen Xin, Young-Jae Cho, Zaibo Li, Xiaoli Zhang, Chunhong Yan, Qingfei Zheng, Hongbing Wang, Deliang Guo, Baek Kim, Junran Zhang
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity. Nature communications 15 (1) (2024)
Chandra Bhushan Prasad, Adrian Oo, Yujie Liu, Zhaojun Qiu, Yaogang Zhong, Na Li, Deepika Singh, Xiwen Xin, Young-Jae Cho, Zaibo Li, Xiaoli Zhang, Chunhong Yan, Qingfei Zheng, Hongbing Wang, Deliang Guo, Baek Kim, Junran Zhang
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity. Nature communications 15 (1) (2024)
Zhipeng Hong, Tao Liu, Lingfeng Wan, Pengyan Fa, Pankaj Kumar, Yanan Cao, Chandra Bhushan Prasad, Zhaojun Qiu, Joseph Liu, Hongbing Wang, Zaibo Li, Hongbing Wang, Peixuan Guo, Deliang Guo, Ayse S Yilmaz, Lanchun Lu, Ioanna Papandreou, Naduparambil K Jacob, Chunhong Yan, Xiaoli Zhang, Qing-Bai She, Zhefu Ma, Junran Zhang
Targeting Squalene Epoxidase Interrupts Homologous Recombination via the ER Stress Response and Promotes Radiotherapy Efficacy. Cancer research 82 (7) (2022)
Chunming Cheng, Feng Geng, Zoe Li, Yaogang Zhong, Huabao Wang, Xiang Cheng, Yue Zhao, Xiaokui M Mo, Craig M Horbinski, Wenrui Duan, Arnab Chakravarti, Xiaolin Cheng, Deliang Guo
Ammonia stimulates SCAP/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth. Nature metabolism 4 (5) (2022)
Xiang Cheng, Feng Geng, Deliang Guo
DGAT1 protects tumor from lipotoxicity, emerging as a promising metabolic target for cancer therapy. Molecular & cellular oncology 7 (6) (2020)